{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:01:58Z","timestamp":1781186518372,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Spatiotemporal control of RNA therapeutics remains a fundamental challenge limiting clinical translation. Here, we develop a photoactivatable CRISPR\/Cas13d (paCas13d) system that enables non-invasive, light-controlled RNA manipulation in deep tissues. Through structure-guided engineering, we identify optimal split sites within RfxCas13d and create light-switchable fragments using CRY2PHR\/CIBN optogenetic dimerization. To overcome the limited tissue penetration of blue light, we engineer polyethylenimine-functionalized upconversion nanoparticles (UCNPs-PEI) that serve dual roles as gene carriers and photon transducers, converting tissue-penetrating near-infrared (NIR) to blue light. The UCNPs-PEI@paCas13d system achieves precise spatiotemporal control of RNA targeting within bone tissue in vivo. In a murine steroid-associated osteonecrosis model, NIR-activated paCas13d achieves robust TET3 knockdown, disrupting the TET3-5hmC-PTEN axis that drives glucocorticoid-induced osteocyte apoptosis. This targeted intervention prevents bone deterioration, with treated mice showing preserved trabecular architecture, enhanced bone volume, and favorable shifts in bone turnover markers, while maintaining systemic glucocorticoid efficacy. Our platform combines the programmability of CRISPR\/Cas13d with non-invasive optical control, offering a versatile approach for treating diseases requiring localized RNA modulation while minimizing systemic effects.<\/jats:p>","DOI":"10.1038\/s41467-026-72181-6","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:08:15Z","timestamp":1776683295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photoactivatable CRISPR\/Cas13d via upconversion nanoparticles for deep tissue RNA engineering and orthopedic therapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0770-2999","authenticated-orcid":false,"given":"Jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zukang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-0011","authenticated-orcid":false,"given":"Jun","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-760X","authenticated-orcid":false,"given":"Jinbin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6631-2080","authenticated-orcid":false,"given":"Xinlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"72181_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature24049","volume":"550","author":"OO Abudayyeh","year":"2017","unstructured":"Abudayyeh, O. O. et al. RNA targeting with CRISPR-Cas13. Nature 550, 280\u2013284 (2017).","journal-title":"Nature"},{"key":"72181_CR2","doi-asserted-by":"crossref","unstructured":"Hart, S. K. et al. Precise RNA targeting with CRISPR-Cas13d. Nat. Biotechnol. 44, 64\u201369 (2026).","DOI":"10.1038\/s41587-025-02558-3"},{"key":"72181_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41587-023-01830-8","volume":"42","author":"HH Wessels","year":"2024","unstructured":"Wessels, H. H. et al. Prediction of on-target and off-target activity of CRISPR-Cas13d guide RNAs using deep learning. Nat. Biotechnol. 42, 628\u2013637 (2024).","journal-title":"Nat. Biotechnol."},{"key":"72181_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57792-9","volume":"16","author":"I Moreno-Sanchez","year":"2025","unstructured":"Moreno-Sanchez, I. et al. Enhanced RNA-targeting CRISPR-Cas technology in zebrafish. Nat. Commun. 16, 2591 (2025).","journal-title":"Nat. Commun."},{"key":"72181_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41587-021-01030-2","volume":"40","author":"S Kannan","year":"2022","unstructured":"Kannan, S. et al. Compact RNA editors with small Cas13 proteins. Nat. Biotechnol. 40, 194\u2013197 (2022).","journal-title":"Nat. Biotechnol."},{"key":"72181_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36316-3","volume":"14","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches. Nat. Commun. 14, 752 (2023).","journal-title":"Nat. Commun."},{"key":"72181_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.tig.2022.05.014","volume":"38","author":"TH Lan","year":"2022","unstructured":"Lan, T. H., He, L., Huang, Y. & Zhou, Y. Optogenetics for transcriptional programming and genetic engineering. Trends Genet. 38, 1253\u20131270 (2022).","journal-title":"Trends Genet."},{"key":"72181_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2021.08.035","volume":"135","author":"Y Lin","year":"2021","unstructured":"Lin, Y. et al. Applications of upconversion nanoparticles in cellular optogenetics. Acta Biomater. 135, 1\u201312 (2021).","journal-title":"Acta Biomater."},{"key":"72181_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44867-2","volume":"15","author":"J Yu","year":"2024","unstructured":"Yu, J., Shin, J., Yu, J., Kim, J., Yu, D. & Heo, W. D. Programmable RNA base editing with photoactivatable CRISPR-Cas13. Nat. Commun. 15, 673 (2024).","journal-title":"Nat. Commun."},{"key":"72181_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.aaq1144","volume":"359","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics. Science 359, 679\u2013684 (2018).","journal-title":"Science"},{"key":"72181_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nbt.3149","volume":"33","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B., Volz, S. E. & Zhang, F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat. Biotechnol. 33, 139\u2013142 (2015).","journal-title":"Nat. Biotechnol."},{"key":"72181_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nmeth.1524","volume":"7","author":"MJ Kennedy","year":"2010","unstructured":"Kennedy, M. J., Hughes, R. M., Peteya, L. A., Schwartz, J. W., Ehlers, M. D. & Tucker, C. L. Rapid blue-light-mediated induction of protein interactions in living cells. Nat. Methods 7, 973\u2013975 (2010).","journal-title":"Nat. Methods"},{"key":"72181_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25993-7","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Near-infrared manipulation of multiple neuronal populations via trichromatic upconversion. Nat. Commun. 12, 5662 (2021).","journal-title":"Nat. Commun."},{"key":"72181_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00198-021-05947-x","volume":"32","author":"A Krez","year":"2021","unstructured":"Krez, A. et al. Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis. Osteoporos. Int. 32, 2095\u20132103 (2021).","journal-title":"Osteoporos. Int."},{"key":"72181_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","volume":"365","author":"RS Weinstein","year":"2011","unstructured":"Weinstein, R. S. Clinical practice. Glucocorticoid-induced bone disease. N. Engl. J. Med. 365, 62\u201370 (2011).","journal-title":"N. Engl. J. Med."},{"key":"72181_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/jbmr.2992","volume":"32","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. TET3 mediates alterations in the epigenetic marker 5hmC and Akt pathway in steroid-associated osteonecrosis. J. Bone Min. Res. 32, 319\u2013332 (2017).","journal-title":"J. Bone Min. Res."},{"key":"72181_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.159","volume":"6","author":"R Bose","year":"2015","unstructured":"Bose, R. et al. Tet3 mediates stable glucocorticoid-induced alterations in DNA methylation and Dnmt3a\/Dkk1 expression in neural progenitors. Cell Death Dis. 6, e1793 (2015).","journal-title":"Cell Death Dis."},{"key":"72181_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54044-0","volume":"15","author":"I Mulet","year":"2024","unstructured":"Mulet, I. et al. TET3 regulates terminal cell differentiation at the metabolic level. Nat. Commun. 15, 9749 (2024).","journal-title":"Nat. Commun."},{"key":"72181_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cell.2018.09.001","volume":"175","author":"C Zhang","year":"2018","unstructured":"Zhang, C. et al. Structural basis for the RNA-guided ribonuclease activity of CRISPR-Cas13d. Cell 175, 212\u2013223 e217 (2018).","journal-title":"Cell"},{"key":"72181_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5925","volume":"5","author":"A Taslimi","year":"2014","unstructured":"Taslimi, A. et al. An optimized optogenetic clustering tool for probing protein interaction and function. Nat. Commun. 5, 4925 (2014).","journal-title":"Nat. Commun."},{"key":"72181_CR21","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1039\/C7SC02956J","volume":"8","author":"WF Lai","year":"2017","unstructured":"Lai, W. F., Rogach, A. L. & Wong, W. T. Molecular design of upconversion nanoparticles for gene delivery. Chem. Sci. 8, 7339\u20137358 (2017).","journal-title":"Chem. Sci."},{"key":"72181_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","volume":"362","author":"J Casper","year":"2023","unstructured":"Casper, J., Schenk, S. H., Parhizkar, E., Detampel, P., Dehshahri, A. & Huwyler, J. Polyethylenimine (PEI) in gene therapy: current status and clinical applications. J. Control. Release 362, 667\u2013691 (2023).","journal-title":"J. Control. Release"},{"key":"72181_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jot.2018.07.001","volume":"16","author":"K Shidara","year":"2019","unstructured":"Shidara, K., Mohan, G., Evan Lay, Y. A., Jepsen, K. J., Yao, W. & Lane, N. E. Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains. J. Orthop. Translat. 16, 91\u2013101 (2019).","journal-title":"J. Orthop. Translat."},{"key":"72181_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41587-022-01419-7","volume":"41","author":"H Tong","year":"2023","unstructured":"Tong, H. et al. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects. Nat. Biotechnol. 41, 108\u2013119 (2023).","journal-title":"Nat. Biotechnol."},{"key":"72181_CR25","doi-asserted-by":"crossref","unstructured":"Zhang, F. et al. Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy. Nat. Biotechnol. 43, 2054\u20132067 (2025).","DOI":"10.1038\/s41587-024-02535-2"},{"key":"72181_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb1777","volume":"6","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Engineering a far-red light-activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors. Sci. Adv. 6, eabb1777 (2020).","journal-title":"Sci. Adv."},{"key":"72181_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801132","volume":"8","author":"N Yu","year":"2019","unstructured":"Yu, N., Huang, L., Zhou, Y., Xue, T., Chen, Z. & Han, G. Near-infrared-light activatable nanoparticles for deep-tissue-penetrating wireless optogenetics. Adv. Healthc. Mater. 8, e1801132 (2019).","journal-title":"Adv. Healthc. Mater."},{"key":"72181_CR28","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/C4CS00158C","volume":"44","author":"NM Idris","year":"2015","unstructured":"Idris, N. M., Jayakumar, M. K., Bansal, A. & Zhang, Y. Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications. Chem. Soc. Rev. 44, 1449\u20131478 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"72181_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduct. Target Ther. 8, 202 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"72181_CR30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.addr.2012.03.013","volume":"64","author":"CH Evans","year":"2012","unstructured":"Evans, C. H. Gene delivery to bone. Adv. Drug Deliv. Rev. 64, 1331\u20131340 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72181_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122328","volume":"302","author":"Q Zou","year":"2023","unstructured":"Zou, Q. et al. Photoactivatable base editors for spatiotemporally controlled genome editing in vivo. Biomaterials 302, 122328 (2023).","journal-title":"Biomaterials"},{"key":"72181_CR32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s10103-017-2317-4","volume":"32","author":"C Ash","year":"2017","unstructured":"Ash, C., Dubec, M., Donne, K. & Bashford, T. Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med. Sci. 32, 1909\u20131918 (2017).","journal-title":"Lasers Med. Sci."},{"key":"72181_CR33","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.cell.2025.01.034","volume":"188","author":"S Zilberzwige-Tal","year":"2025","unstructured":"Zilberzwige-Tal, S. et al. Reprogrammable RNA-targeting CRISPR systems evolved from RNA toxin-antitoxins. Cell 188, 1925\u20131940 e1920 (2025).","journal-title":"Cell"},{"key":"72181_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/ijo.2025.5748","volume":"66","author":"KS Allemailem","year":"2025","unstructured":"Allemailem, K. S. et al. Current updates on the structural and functional aspects of the CRISPR\/Cas13 system for RNA targeting and editing: a next\u2011generation tool for cancer management (Review). Int. J. Oncol. 66, 42 (2025).","journal-title":"Int. J. Oncol."},{"key":"72181_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1021\/acscentsci.9b00300","volume":"5","author":"A Lay","year":"2019","unstructured":"Lay, A. et al. Optically robust and biocompatible mechanosensitive upconverting nanoparticles. ACS Cent. Sci. 5, 1211\u20131222 (2019).","journal-title":"ACS Cent. Sci."},{"key":"72181_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"72181_CR37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41587-020-0456-9","volume":"38","author":"HH Wessels","year":"2020","unstructured":"Wessels, H. H., Mendez-Mancilla, A., Guo, X., Legut, M., Daniloski, Z. & Sanjana, N. E. Massively parallel Cas13 screens reveal principles for guide RNA design. Nat. Biotechnol. 38, 722\u2013727 (2020).","journal-title":"Nat. Biotechnol."},{"key":"72181_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1021\/cr400478f","volume":"115","author":"J Zhou","year":"2015","unstructured":"Zhou, J., Liu, Q., Feng, W., Sun, Y. & Li, F. Upconversion luminescent materials: advances and applications. Chem. Rev. 115, 395\u2013465 (2015).","journal-title":"Chem. Rev."},{"key":"72181_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201907301","volume":"16","author":"J Zhao","year":"2020","unstructured":"Zhao, J., Li, B., Ma, J., Jin, W. & Ma, X. Photoactivatable RNA N(6) -methyladenosine editing with CRISPR-Cas13. Small 16, e1907301 (2020).","journal-title":"Small"},{"key":"72181_CR40","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/acs.inorgchem.6b02479","volume":"56","author":"W Kong","year":"2017","unstructured":"Kong, W. et al. A general strategy for ligand exchange on upconversion nanoparticles. Inorg. Chem. 56, 872\u2013877 (2017).","journal-title":"Inorg. Chem."},{"key":"72181_CR41","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1359\/jbmr.1997.12.12.2014","volume":"12","author":"Y Kato","year":"1997","unstructured":"Kato, Y., Windle, J. J., Koop, B. A., Mundy, G. R. & Bonewald, L. F. Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Min. Res. 12, 2014\u20132023 (1997).","journal-title":"J. Bone Min. Res."},{"key":"72181_CR42","doi-asserted-by":"crossref","unstructured":"Gu, P. et al. An Inducible CRISPR-dCas9-Based Transcriptional Repression System for Cancer Therapy. Small Methods 8, e2301310 (2024).","DOI":"10.1002\/smtd.202301310"},{"key":"72181_CR43","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jbmr.4253","volume":"36","author":"B Li","year":"2021","unstructured":"Li, B. et al. Cross-talk between histone and DNA methylation mediates bone loss in hind limb unloading. J. Bone Min. Res. 36, 956\u2013967 (2021).","journal-title":"J. Bone Min. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72181-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:35:37Z","timestamp":1781184937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72181-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72181"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72181-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5216"}}